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Background & Objectives: Aedes aegypti is the main vector of dengue and chikungunya 
diseases. This mosquito is known to have proteins and fats that play a role in the process of life. 
This study aims to determine the fraction of protein and fat content of Aedes aegypti larvae and 
its ability to inhibit the growth of Escherichia coli bacteria. Methods: Fractionation of protein 
with ammonium sulfate at levels of 0-30%, 30-40%, 40-60%, and 60-80%. Determination of 
protein content by Lowry method and fat by standard laboratory operations. Test of 
effectiveness by measuring the diameter of inhibition zone around the paper disc. Result: The 
results of protein content measurements using 0.2 ml with 10 times dilution showed that 30-
40 % of fraction contains highest levels of total protein 5.26 mg and lowest in the 0-30 % 
fraction 3.76 mg. The results of protein content measurements using 0.02 ml of sample extract 
with 100 times dilution showed that 40-60 % of fraction contains the highest total protein 
content 27.03 mg and lowest in the 0-30% fraction 4.88 mg. Fat content is only found in the 
protein fraction of 0-30% and 30-40 %. Result of effectiveness test showed that protein 
fraction of 30-40% and 60-80 % are bakteriocide. Fraction of 30-40 % has 0.6 % fat content 
and the fraction of 60-80 % have no fat content. Crude extract, fractions of 0-30 %, and 40-60 % 
are bacteriostatic. Protein fraction of 0-30 % has fat content of 0.8%, while the crude extract 
and fractions of 40-60 % do not have fat content. Interpretation & Conclusion: Protein fraction 
of Ae.aegypti showed inhibition to the  growth of E. coli. Fat content does not give effect to 
bacteriostatic or bacteriocide of  bioactive compounds of Ae.aegypti.
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Dengue Haemorrhagic Fever, also called as DHF, is a tropical 
disease caused by the dengue virus and transmitted by the 
mosquito of Aedes aegypti Linnaeus as the main vector and Aedes 
1, 2
albopictus Skuse as secondary vector . Dengue Haemorrhagic 
Fever (DHF) in Indonesia was reported for the first time in Surabaya 
and in Jakarta in 1968 and 1969. In Makassar city, dengue disease 
was firstly discovered in 1975 and then spread to several 
3
districts/cities in South Sulawesi .
Ae.aegypti is one of members of the family Culicidae which is a 
disease vector to human and animal. This mosquito is also known as 
the yellow fever mosquito, and is a domestic mosquito species that 
can live long at adult stage. This mosquito is also vector of 
chikungunya disease4, 5. Adult mosquito breeding supported by 
nutrition derived from natural herbs in the form of liquid/flower 
nectar for males and females in the form of protein obtained 
through the blood of the host. Proteins contained in the blood is 
6
used by female mosquitoes to maturing the eggs . For larval stages, 
food in the form of tiny particles present in the water, including 
4
bacteria and fungi .
Larvae of Ae. aegypti was found living in densely populated 
7, 8
settlements, both in urban and rural   on various container such as 
9 4
water bath, water drums, jars, buckets , ponds, and tree holes , 
10
flower pots in the yard, and vases of flowers in the house . Recently 
Ae. aegypti larvae found breeding in the well both indoor and 
11, 12
outdoor . Adult mosquitoes suck the blood in the morning until 
late afternoon, now it was also found to be active in dusk until night 
13, 14
to feed on blood .
Ae. aegypti is commonly found laying eggs in the container that 
contains Acinetobacter calcoaceticus, Enterobacter cloacae, 
Pseudomonas gladialli  and Pseudomonas alcaligenes 
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15, 16
bacterium . The presence of bacteria affects the percentage of egg 
17
laying of  Ae. aegypti . Various studies indicate that both larval and 
adult stages of Ae. aegypti contain bacteria in the gut. Types of 
bacteria found in the larval midgut, such as Escherichia coli and 
Aeromonas are known to influence the susceptibility of adult 
18, 20
mosquitoes to dengue viruses . Bacteria presenting in the 
mosquito midgut is also known to stimulate immune activity that 
protects the mosquito from dengue viral infection19.
The results of the study of larval protein of Ae. aegypti indicates 
that larvae infected by Varvaria culicis and Edhazardia aedis 
17
parasites has  types of proteins which several proteins identified 
such as actin and ferritin are known to play a role to protect the host 
22
from patogen attack . Antibacterial protein has several advantages 
that are very promising because it can be well accepted by the 
human body and cause fewer side effects because proteins are 
formed naturally, so the research began to be developed step 
23
towards treatment by using protein .
10
Various studies concerning of distribution of Ae. aegypti , 
larval mortality using extracts of neem and ylang plant24 as well as 
various research concerning these mosquitoes have been carried 
out. However, studies that determine the extent to which the 
effectiveness or inhibition of larval protein of Ae. aegypti against 
bacterial growth to date has not been done. This research is an effort 
and early step in finding the benefits of larval protein of Ae. aegypti 
and its ability to inhibit the growth of E. coli. This study is based on 
the idea to find a natural compound material of animal origin which 
may be used as raw material for medicine. There is a possibility that 
larvae protein of Ae. aegypti can be used as raw material for drugs 
later in the future.
This is an experimental research which conducted in March to 
July, 2011. Samples of Aedes aegypti larvae taken from the village of 
Kampung Beru, Regency of Takalar and Pa'lanassang village, 
Makassar. Sampling sites is the place where most of mosquitos 
acquire and is the centre of laboratory stock. The samples obtained 
were washed with water and examined under a microscope to 
determine the species.  They are then kept in petridish and stored in 
a freezer at -20C. Fractionation of larvae protein of Ae.aegypti is 
done in the Laboratory of Biochemistry Department of Chemicals 
and the test of effectiveness is conducted in the Laboratory of 
Microbiology Department of Biology, Faculty of Mathematics and 
Natural Sciences, Hasanuddin University, Makassar.
1. Material research : 50 g Aedes aegypti larva, Escherichia 
coli bacteria, Agar Nutrient (NA) medium, Muller Hinton Agar 
(MHA), Buffer A (0,1 M Tris HCl pH 8,3, 0,01 M CaC , B 
l2
merkaptoetanol 1 %, Triton-X 100 0,5 %), Buffer B (0,1 M Tris HCl 
pH 8,3, 0,2 M NaCl 0,01 M CaC  ), Buffer C (0,01 M Tris HCl pH 8,3, 0,2 
l2
M NaCl 0,01 M CaC ), lowry A (folin, aquades), lowry B (Na CO  2 %, 
l2 2 3
NaOH 0,1 N, CuSO  1 %, NaKC H6OH.4H O), aquadest, aluminium 
4 4 2
foil, Bovine Serum Albumin (BSA). 
1. Preparation of sample includes the preparation of crude 
extract of larval protein of Ae. aegypti and E. coli bacteria. Crude 
extract is done by smoothing the larva of  Ae. aegypti by using 
mortar then added with buffer A. After being mixed, it was filtered 
with a Buchner funnel to produce a filtrate/crude extract. 
Preparation of bacteria by rejuvenating the bacteria25 through 
inoculating E. coli  from pure cultures (1 loop) and scratched on 
oblique medium of Nutrient Agar (NA). Bacterial culture on oblique 
agar is incubated at 37°C for 15 hours. Preparation of bacterial 
suspension for test is done by taking each of the E. coli  as much as 1 
Ose then suspended in sterile distilled water solution. Dilutions of 
the bacterial suspension up to 25% transmittance of the blank 
solution of sterile distilled water at a wavelength of 520 nm is then 
conducted. Control solution, as positive control, antibiotic 
ampicillin trihydrate (0.04 g) and Bovine Serum Albumin (BSA) as 
negative control (0.01 mg/ml.) are used. Preparation of paper disc 
for test the effectiveness, paper discs ( = 0.5 cm) as much as 7 sheets 
are poured with 0.2 ml of protein fraction 0-30 % (J1) , protein 
fraction 30-40 % (J2), fraction protein 40-60 % (J3), protein 
fraction 60-80 % (J4) , crude extract  (J5), BSA as negative control 
(K-), ampicillin trihydrate as positive control (K+) .
2. Fractination of Protein and Dialysis 
Crude extract is fractionated and dialyzed. Protein fractionation 
is performed using ammonium sulfate with saturation levels of 0 – 
30 % (F1), 30 – 40 (F2), 40 – 60 % (F3), 60 – 80 % (F4). Deposition 
results of the fractionation of each ammonium sulfate saturation 
levels are put in a cellophane bag and further dialyzed with buffer B 
and then with buffer C. Cellophane that has been filled with the 
protein fraction is put into a beaker containing a solution of buffer B 
and then stirred with a magnetic stirrer. 
The dialysis process was continued by replacing the buffer 
solution B with buffer C until the buffer solution become colorless 
again. Dialysis process is performed to purify the protein from small 
molecules and minerals that are not needed. To determine the 
protein content of each fraction, Lowry method is applied by using 
serum albumin Bovin (BSA) as a standard solution. We then 
measured the fat content of each protein fraction and crude extract. 
The final stage is to test the effectiveness of the protein fraction of 
larval Ae . aegypti and crude extract towards the growth of E. coli 
bacteria.
3. Test of effectiveness is conducted in vitro by agar 
diffusion method using paper disc. Suspension bacterial test of 
transmittance 25% put in a petridish as much as 1 ml, then added 
with MHA sterile medium (which is cooled at a temperature of 40C - 
45C) as much as 20 ml aseptically and homogenized. After that, as 
much as 7 sheets of paper disc are placed aseptically with sterile 
forceps on the surface of medium with the distance from one to 
another disc is 2-3 cm from the edge of the petridish. Furthermore, 
it is incubated at 37°C for 12 hours, 24 hours, 36 hours, and 48 
hours. Observations were made by measuring the diameter of 
bacterial growth inhibition around the paper discs using calipers. 
To see the ability of the protein compounds of Ae. aegypti in 
inhibiting the growth of E. Coli, measurement is performed in the 
incubation period of 12 hours, 24 hours, 36 hours and 48 hours.
Material and Methods
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Result 
The results of the content of crude protein extract of Ae. aegypti 
larvae, the protein fraction of 0-30%, 30-40%, 40-60%, 60-80% and 
fat as well as the inhibitory ability against the growth of E. coli 
bacteria are presented as follows:
1. The content of protein and fat of Aedes aegypti larva
The content of protein extract of Ae . aegypti larvae is done by 
determining the maximum uptake (maximum ɻ), the absorbance of 
standard solution (BSA) and the equation of the calibration curve 
standard solutions. The results of measurements of maximum 
absorption (maximum ɻ ) are presented in Table 1. 
Table 1 shows that the maximum ɻ at BSA concentration of 0.06 mg / 
ml was 690 nm.
The results of measurements of the absorbance of standard 
solutions are presented in Table 2. Table 2 shows that the 
absorbance of standard solution concentration (BSA) increases due 
to increasing concentration of the standard solution.
The results of the determination of the calibration curve 
equation is presented in Figure 1. Based on the Figure 1, the 
regression of standard solution with line equation : Y = 3.225 x + 
0.110 is known.
The results of protein concentration measurements using 0.2 
ml sample extract with 10 times dilution are presented in Table 3. 
Table 3 shows that the highest of total protein fractions is obtained 
from 30-40 % ( 5.26 mg ) and the lowest fraction is from 0-30 % 
(3.76 mg) .
The results of protein concentration measurements using 0.02 
ml of sample extract with 100 times dilution are presented in Table 
4. Table 4 shows that the highest of total protein fraction is obtained 
from 40-60 % (27.03 mg) and the lowest fraction is from 0-30 % 
(4.88 mg). The volume of the sample with the smallest value of 0.02 
ml shows that the protein level is greater than 0.2 ml of sample 
volume.
Fat measurement results are presented in Table 5. Table 5 
shows that the fat content is only found in the protein fraction 
contained 0-30 % and 30-40 % .
1. Test of effectiviness of protein extract and fat of Aedes 
aegypti againt the growth of Escherichia coli 
Measurement of the effectiveness of Ae. aegypti extracts against 
E. coli is seen through the presence of a clear zone (zone of 
inhibition) around the paper disc. The result of the effectiveness 
test is presented in Table 6 and Figure 1. Table 6 shows that the 
highest average of inhibition zone for incubation period of 24 hours 
is shown by the crude extract (J5) (11.46 mm), and the lowest 
fraction of 0-30 % (J1) (6.16 mm). The highest average of inhibition  
zone for incubation period of 48 hours is shown by the crude extract 
(J5) (11.70 mm), and lowest in the 40-60 % of fraction (J3) (6.31 
mm). The highest average of inhibition zone for incubation period 
of 72 hours is shown in the crude extract (J5) (11.43 mm), and the
 lowest fraction of 40-60 % (J3) (5.85 mm). The measurement 
results indicate that the negative control (BSA) (K-) showed no 
inhibition zone, whereas the positive control (ampicillin) (K+) in 
the incubation period of 24 hours showed inhibition zone of 10.25 
mm, further decline due to incubation period.
Protein fractions of 0-30 % (J1) showed an increasing and 
decreasing of average of inhibition zone during in the incubation 
period of 24 to 72 hours. Similarly, the crude extract  (J5) is also 
increased and decreased in terms of average inhibition zone at 
incubation period of 24-hour of 11,46 mm, at 48-hour incubation of 
11.70 mm, and at 72 hours incubation of 11.43 mm. The protein 
fraction of 30-40 % (J2) shows an increase in the average of 
inhibition zone during incubation period. At the 24-hour 
incubation, inhibition zone is 6.20 mm, incubation period of 48-
hours is  6.55 mm, and incubation period 72-hour is 7.00 mm. 
Similarly, the  fraction of 60–80% (J4) shows the increase of 
inhibition zone average during incubation period. The 24-hour 
incubation period is 7,91 mm, period 48-hours is 8,08 mm, and 72-
hours incubation is 9,50 mm. Otherwise, the protein fraction of 40 – 
60% (J3) shows a decrease of average inhibition zone due to the 
increase of incubation period. 
The result of effectiveness test shows that protein extracts 
prove properties of bacteriocide is protein fraction of 30-40 % (J2) 
and the fraction of 60-80 % (J4). Fraction of 30-40 % (J2) has 0.6 % 
of fat content and the fraction of 60-80 % (J4) has no fat content. The 
highest fat content of protein fractions is indicated by 0-30 % (J1) 
where the fraction of 0-30 % (J1) is bacteriostatic only.
Wattimena (1991)29 states that if the inhibition zone formed 
after an incubation period of 48 hours remains the same or 
diameter of the inhibition zone is increased, it can be said that the 
extract are bacteriocide. Whereas if the inhibition zone formed on 
the 24-hour incubation period is covered back with population of 
bacteria and the decrease of inhibition zone appears at 48-hour 
incubation period, it can be said that the extract is bacteriostatic. An 
active compound is said to be bacteriostatic if the active compound 
efficaciously inhibit microbial growth but does not kill microbes.
Table 1. Maximum absorbance (ɻ maximum) at standard 
solution of absorbance of concentration of 0,06 mg/ml
Wave length (nm
650
655
660
665
670
675
680
685
690
695
700
Absorbace (A)
0,274
0,276
0,278
0,281
0,282
0,282
0,282
0,284
0,285(ɻ max)
0,284
0,282
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Table 2: Knowledge and practices regarding menstruation in the study population.
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Graphic 1. Calibration curve of protein standard solution (BSA) in 
maximum wave length (ɻ max) of 690 nm
Table 2. Absorbance of solution (BSA) in maximum wave length 
(ɻ maks)  at  690 nm 
Table 3. Protein level with 0,2 ml of samples (10 times dilution)
Figure 1. Average inhibitory zone of protein fraction and larval 
crude extract of Aedes aegypti towards the growth of Escherichia 
coli bacteria
Note: K- : negative control (BSA), K+: positive control 
(Ampicillin), J1: fraction 0 – 30 %, J2:  fraction 30 – 40%,  J3:  fraction  
40 – 60%, J4:  fraction  60 – 80%,  J5:  crude extract
1. Effect of extract volume of Aedes aegypti to the level of 
protein
The results showed that the larvae of Ae . aegypti has a protein 
content. Sample volume of 0.2 ml and 0.02 ml affect the amount of 
total protein content. Differences in levels of the protein may be 
caused by sample turbidity. The more turbid the sample, the less light 
absorption of the sample and thus the absorbance shown by a 
spectrophotometer is too small. Conversely, the bright sample will 
facilitate the absorption of light so that the absorbance of the sample 
Discussion
Table 4. Level of  Protein with 0,02 ml of samples (100 times 
dilution)
Note: a = weight of empty bottle,  b = weight of sample after  being in 
the oven
Table 6.  Average inhibition zone of  protein fraction of Aedes 
aegypti and control to the growth of  Escherichia coli (mm)
Table 5.  Fat level of Aedes aegypti
Repetition I      Repetition II Repetition III
Andi Ernawati et al.  Int J Biol Med Res. 2014; 5(3):4197-4202
4201
is easily legible. Effect of sample thickness affects the absorbed 
light. It is in line with the law of Lambert beer26. The absorbed light 
is measured as absorbance (A) while the scattered light is measured 
as transmittance (T) which expressed by Lambert - beer law saying 
that the amount of visible light radiation (ultraviolet, infrared, etc.) 
that is absorbed or transmitted by a solution is an exponential 
function of concentration and thickness solution.
Food larval of Ae. aegypti in the form of tiny particles contained 
in the water including bacteria, fungi and protozoa4. Larvae obtains 
protein from the substances contained in the water. Proteins 
contained in the larval body is from the mother mosquito obtained 
from the blood of the host in this case is a human as a source of food. 
Larval development is affected by the formation of the protein, fat, 
and carbohydrate27. The results shows that feeding with valine, 
leucine, isoleucine, phenylalanine, histidine, tryptophan, threonine, 
and lysine methionin will stimulate the growth of larvae26.
2. The result of effectiveness of protein extract of Aedes 
aegypti larva towards the growth of Escherichia coli
The results of effectiveness shows that crude extract  and protein 
fractions of Ae. aegypti larvae are able to inhibit the growth of E. coli 
. Each test sample of both crude extracts and protein fractions 
during the incubation period of 3 x 24 hours shows a zone of 
inhibition, except in the negative control which shows no inhibition 
zone. Capuccino and Sherman (1992)30 state that if the diameter of 
the inhibition zone indicated  by a compound/antibiotics for > 14 
mm then it is said to be effective in inhibiting the growth of bacteria, 
if the inhibition zone diameters of 10-11 mm are obtained it is said 
to be less effective, and if the diameter inhibition zone ≤  9 mm 
obtained the compounds/ antibiotics are not effective in inhibiting 
the growth of bacteria.
The results of this study indicate that the fractions of 0-30 % 
(J1) , 30-40 % (J2) , and 40-60 % (J3) are not effective in inhibiting 
the growth of bacteria while the crude extract is less effective in 
inhibiting the growth of bacteria which makes it less effective if 
used as antibiotics. Protein fractions that are less/not effective in 
inhibiting the growth of bacteria may be caused by the chemical 
activity of the substance itself, the diffusion of the active ingredient 
at a slow medium and low concentrations of active substances, and 
thus the fraction can not optimally inhibit bacteria30. The size of the 
inhibition zone formed may be influenced by the levels of the active 
substance in the form of proteins in each fraction and crude extract. 
Because the number of extracted larvae sample is not too much (50 
g),  it is possible if the crude extract and proteins fraction will show 
higher inhibitory response (bacteriocide) if the number of larval 
samples is also increased.
Bioactivity benchmark indicated by the size of the inhibition 
zone diameter of a compound/antibiotic is influenced by several 
factors including: the rate of growth of microorganisms, resistance 
of bacteria against bioactive substance, the active substance 
concentration, amount of inoculum bacteria/bacterial density test 
as well as the concentration of an antimicrobial contained in the 
sampel31. This is a natural mechanism of bacterial cells in 
maintaining their life32. During the incubation period, fraction that 
has an increasing inhibition zone is the fraction of 30-40 % (J2) and 
the fraction of 60-80 % (J4). This indicates that the fraction of 30-40 
% (J2) and the fraction of 60-80 % (J4) is bacteriocide. According to 
Wattimena (1991)29 if the inhibition zone formed after an 
incubation period of 48 hours remains the same or an expansion in 
the diameter of the inhibition zone of the extract appear, it can be 
said to be bacteriocide. Crude extract (J5), the fraction of 0-30 % 
(J1), 40-60 % (J3) shows an increase and decrease of inhibition 
zone during incubation period and around the paper disc 
overgrown with bacteria. According to Wattimena (1991) if the 
inhibition zone formed at the 24-hour incubation period covered 
back with bacteria, diameter of inhibition zone is reduced to 48-
hour incubation period, it can be said that the extract is 
bacteriostatic. An active compound is said to be bacteriostatic if the 
active compound efficaciously inhibit microbial growth but does 
not kill mikroba29.
Protein fraction that shows bacteriocide properties are 
fractions of 30-40 % (J2) and 60-80 % (J4). The highest protein 
content was obtained from fraction of 40-60 % (J3) but this fraction 
shows only bacteriostatic effect. This shows that the size of the 
protein content does not determine whether or not a substance 
effective influences the growth of bacteria, but may be influenced by 
the levels of the active substance in the form of protein type in each 
fraction and crude extract. When viewed from the size of the fat 
content contained in this Ae.aegypti larvae samples, it can be said 
that the fat content does not affect bacteriocide or bacteriostatic 
properties of an active compound.
The results of this study indicate that the larvae of Ae. aegypti 
has a protein content that shows inhibitory response to the growth 
of E. coli but can not be used as raw material for 
medicine/antibiotics given that barrier zone that is displayed is not 
too large. However, further research is needed to re-examine the 
content and type of the protein fraction in order to achieve a 
maximal result.
Conclusion
Based on the research, it can be concluded that: 
1. Extract of Aedes aegypti larvae contains proteins that shows 
inhibition to the growth of Escherichia coli bacteria although it is 
not effectively used as an antibiotic because the diameter of the 
barriers obtained is <9 mm. 
2. Protein fraction of 30-40%, 60-80% are bacteriocide while 
crude extract, 0-30%, and the fraction of 40-60% are bacteriostatic.
Andi Ernawati et al.  Int J Biol Med Res. 2014; 5(3): 4197-4202
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